Search
Search Results
##search.searchResults.foundPlural##
-
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2149PDF: 1707HTML: 380 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
4000PDF: 1520HTML: 9191Untitled: 281Untitled: 188Untitled: 173Untitled: 167Untitled: 189Untitled: 344 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
2113PDF: 1533HTML: 495 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7642PDF: 2431HTML: 1739Table 1.: 211Table 2.: 219Table 3.: 205Table 4.: 204 -
Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA
2073PDF: 1898HTML: 350 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3723PDF: 1457HTML: 186 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1256PDF: 1006HTML: 223 -
LENALIDOMIDE IN COMBINATION WITH DEXAMETHASONE IN ELDERLY PATIENTS WITH ADVANCED, RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND RENAL FAILURE
1295PDF: 898HTML: 1280fig 1A: 174figure1B: 150 -
-
IMMUNOLOGY OF TUBERCULOSIS
5346PDF: 2017HTML: 7333Untitled: 195 -
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment
1743PDF: 848HTML: 151 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3388PDF: 1289HTML: 2223Fi.1 Gritti.Rambaldi: 206 -
MOLECULAR MECHANISMS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA Guest Editor: Giancarlo Costaman
3285PDF: 1615HTML: 443 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
4009PDF: 1056HTML: 3599Untitled: 177Cneo. Fig.1: 114Untitled: 105Untitled: 128Untitled: 134 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4249PDF: 3510HTML: 217 -
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4361PDF: 1767HTML: 1111 -
PATIENTS WITH HAEMOGLOBINOPATHIES AND CHRONIC HEPATITIS C: A REALLY DIFFICULT TO TREAT POPULATION IN 2016?
2946PDF: 983HTML: 2065Cover letter: 180 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
1981PDF: 758HTML: 702 -
DIAMOND BLACKFAN ANEMIA: A TERTIARY CARE CENTRE EXPERIENCE
1820PDF: 858HTML: 3594Diamond Blackfan Anemia: A Tertiary care centre experience: 258 -
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL
1652PDF: 1100HTML: 125 -
DRUG THERAPY IN THE PROGRESSED CML PATIENT WITH MULTI-TKI FAILURE
277682PDF: 1801HTML: 3873 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3355PDF: 1480HTML: 4014 -
-
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4794PDF: 2848HTML: 2296 -
Azacytidine failure revisited: an appraisal based on real life data from the MDS registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS). Azacytidine failure revisited
1096PDF: 848HTML: 248 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1269PDF: 530HTML: 23079 -
HODGKIN LYMPHOMA IN CHILDREN: A 16-YEAR EXPERIENCE AT THE CHILDREN’S WELFARE TEACHING HOSPITAL OF BAGHDAD, IRAQ
1046PDF: 939Suppl. Files: 595HTML: 88







